https://orcid.org/0000-0002-9739-2164
References
- Toscani F, Di GP, Brunelli C. How people die in hospital general wards: a descriptive study. J Pain Symptom Manag 2005;30(1):33–40.
- Singer PA, Martin DK, Kelner M. Quality End-of-life care. JAMA 1999;281(2):163–8.
- Ghandourh WA. Palliative care in cancer: managing patients’ expectations. J Med Radiat Sci 2016;63(4):242–57.
- Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet 2012: 58–68.
- Andersen G, Jensen NH, Christrup L, Hansen SH, Sjøgren P. Pain, sedation, and morphine metabolism in cancer patients during long-term treatment with sustained-release morphine. Palliat Med 2002;16(2):107–14.
- Whalen K, Whalen TB. Pharmacology. In: Finkel R, Panavelil TA, eds. Pharmacology. sixth ed. Philadelphia: Wolters Kluwer; 2015.
- Gerlach AT, Murphy C V, Dasta JF. An updated focused review of dexmedetomidine in adults. Ann Pharmacotherapy 2009;43:2064–74.
- Kamibayashi T, Maze M. Clinical uses of α 2 -adrenergic agonists. Anesthesiology 2000;93(5):1345–19.
- Roberts SB, Wozencraft CP, Coyne PJ, Smith TJ. Case discussions dexmedetomidine as an adjuvant analgesic for Intractable cancer pain. J Palliat Med 2011;14(3):3–6.
- Soares LG, Naylor C, Martins MA, Peixoto G. Dexmedetomidine: a new option for intractable distress in the dying. J Pain Symptom Manag 2002 Jul;24(1):6–8.
- Hilliard N, Brown S, Mitchinson S. A case report of dexmedetomidine used to treat intractable pain and delirium in a tertiary palliative care unit. Palliat Med 2015 Mar;29(3):278–81.
- Liu H, Gao X, Liu X, Xia M, Li W, Jin Y. Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain. J Palliat Med 2014;17(7):837–40.
- Hofherr ML, Abrahm JA, Rickerson E. Dexmedetomidine: A novel strategy for patients with Intractable Pain, opioid-induced hyperalgesia, or delirium at the End of life. J Palliat Med 2020.
- Wilson E, David A, MacKenzie N, Grant IS. Sedation during spinal anaesthesia: comparison of propofol and midazolam. Br J Anaesthesia 1990 Jan;64(1):48–52.
- Rudkin GE, Osborne GA, Finn BP, Jarvis DA, Vickers D. Intra-operative patient-controlled sedation. Comparison of patient-controlled propofol with patient-controlled midazolam. Anaesthesia 1992 May;47(5):376–81.
- Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50–55.
- Haefeli M, Elfering A. Pain assessment. Eur Spine J 2006;15:17–24.
- Coyne PJ, Wozencraft CP, Roberts SB, Bobb B, Smith TJ. Dexmedetomidine: exploring its potential role and dosing guideline for its use in intractable pain in the palliative care setting. J Pain Palliat Care Pharmacotherapy 2010;24:384–6.
- Thomas B, Lo W-SA, Nangati Z, Barclay G. Dexmedetomidine for hyperactive delirium at the end of life: An open-label single arm pilot study with dose escalation in adult patients admitted to an inpatient palliative care unit. Palliat med 2021;00(0):1–9.